Titan, Fastrack, Sonata and Xylys watches and wearables.

EyeCare is not a separate tab; the Lenskart signal sits in this division’s risk and is listed under it.

Board risks

Watches premium pivot meets Swiss duty cuts; eyewear faces a faster Lenskart

Medium Score 9 (impact 3 x likelihood 3) | Near | Trend: Stable

Question for the Board: Where do imported Swiss watches and Lenskart hurt first, and are capacity and any acquisition plans sized to the premium bet?

Suggested mitigation: 1) Price-band exposure map versus Swiss entry brands. 2) Capacity and sourcing plan for festive peaks. 3) Acquisition criteria and integration playbook. 4) EyeCare margin and store-productivity benchmark against Lenskart.

Signals

• Low Swiss entry-price watch exports surge in September (2026-10-20, Media) blue News (bluewin)
• Low India-EFTA deal: Swiss watch duties falling toward zero within five years (2026-10-09, Media) Swissinfo
• Low Titan eyes acquisitions of smaller watch brands; capacity limits festive supply (2026-09-21, Secondary) Sahi
• Medium Lenskart Q1 FY27 revenue up 34% with 70% product margin (EyeCare, 2026-08-12, Media) Outlook Business

Group-wide items, such as the Tata Sons governance dispute, are on Titan Risk Watch. Brief dated 2026-10-30.